R. Watanabe
Biomedical Engineering · with Choyke · 2013
A researcher in the Science corpus: 1 paper; trusts 3 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Biomedical Engineering — 9 citations into it
- Molecular Biology — 9 citations into it
- Biomaterials — 7 citations into it
Whom R. Watanabe trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from R. Watanabe's perspective
Ordered by how strongly the researchers R. Watanabe trusts endorse each paper. Same corpus, a different order for every researcher.
- Inhibition of vascular endothelial growth factor (VEGF) signaling in cancer causes loss of endothelial fenestrations, regression of tumor vessels, and appearance of basement membrane ghosts. (American Journal of Pathology)
- Delivering nanomedicine to solid tumors (Nature Reviews Clinical Oncology)
- Imaging of angiogenesis: from microscope to clinic (Nature Medicine)
- Clearance Properties of Nano-sized Particles and Molecules as Imaging Agents: Considerations and Caveats (Nanomedicine)
- Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors. (American Journal of Pathology)
- Renal clearance of quantum dots (Nature Biotechnology)
- The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo. (Advanced Drug Delivery Reviews)
- Molecular regulation of vessel maturation (Nature Medicine)
- Drug targeting to tumors: principles, pitfalls and (pre-) clinical progress. (Journal of Controlled Release)
- Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner (Nature Nanotechnology)